La estructura primaria del oncogén putativo pim-1 muestra una extensa homología con las proteínas quinasas
Video Experimental Relacionado
Updated: Jun 23, 2026
08:05
Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Cell
|August 15, 1986
Resumen
El oncogén pim-1, implicado en los linfomas de células T, tiene una estructura génica definida. Su activación implica la integración del provirus cerca del exón 3 ', lo que lleva a un aumento del ARNm pim-1 y la actividad de la proteína quinasa.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Oncología Oncología.
- Virología Virología.
Sus antecedentes:
- El gen pim-1 es un oncogén putativo activado con frecuencia en los linfomas de células T inducidos por el virus de la leucemia murina.
- Comprender la estructura genética y los mecanismos de activación de pim-1 es crucial para la investigación del cáncer.
Objetivo del estudio:
- Para dilucidar la organización estructural del gen pim-1.
- Para investigar el mecanismo de activación de pim-1 mediante la inserción de provirus.
- Para identificar dominios funcionales potenciales dentro de la proteína pim-1.
Principales métodos:
- Secuenciación de clones genómicos y de ADNc para determinar la estructura genética.
- Análisis de los sitios de integración del provirus en los linfomas de células T.
- Análisis bioinformático para identificar la homología de proteínas y dominios conservados.
Principales resultados:
- El gen pim-1 comprende seis exones con un marco de lectura abierto que codifica una proteína de 313 aminoácidos.
- La integración del provirus se produce preferentemente en el exón 3'-terminal, mejorando los niveles de ARNm pim-1.
- La secuencia de la proteína pim-1 exhibe homología con las proteínacinasas, particularmente las proteína-serina.
Conclusiones:
- La caracterización estructural del gen pim-1 proporciona información sobre su regulación.
- La inserción del provirus en el exón 3' es un mecanismo clave para la activación del pim-1 en los linfomas.
- Pim-1 funciona como una proteína quinasa, lo que sugiere su papel en las vías de señalización celular relevantes para el cáncer.
Videos de Conceptos Relacionados
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...